Veis Alexander A, Dabarakis Nikolaos N, Parisis Nikolaos A, Tsirlis Anastasios T, Karanikola Theodora G, Printza Dimitra V
Department of Alveolar Surgery, Implantology and Radiology, Dental School of the Aristotle University of Thessaloniki, Thessaloniki, Greece.
Implant Dent. 2006 Dec;15(4):386-94. doi: 10.1097/01.id.0000243317.57261.86.
It has been reported that previous Biogran (3i Implant Innovations, Inc., Palm Beach Gardens, FL) can be converted in vitro into hydroxyapatite (Biogran II) to accelerate new bone formation. The purpose of this study was to evaluate the bone regeneration around implants placed in critical-sized defects in rabbit tibia using granular and spherical forms of Biogran II in regards to implant contact, bone-to-graft contact, bone graft area, and total bone volume.
Twelve adult New Zealand rabbits were used, offering 24 surgical sites (1 in each tibia), where 6-mm round defects were created allowing the homocentric insertion of a screw type experimental implant with Osseotite (3i Implant Innovations, Inc.) surface. Half of the defects (group A) were filled up with spherical and half (group B) with granular forms of Biogran II. Ossix (3i Implant Innovations, Inc.) membranes covered the surgical sites.
The histological evaluation after 8 weeks showed new bone formation in both groups, without any statistically significant differences in regards to bone-to-implant contact, bone-to-graft contact, bone graft area, and bone volume. Both dissolution of the outer shell and inner silica gel of the particles were observed mostly in spherical particles. In addition, new bone formation within the protected pouch interconnected with the surrounding new bone was observed exclusively in spherical particles of Biogran II.
Faster dissolution of both outer and inner portions of spherical particles of Biogran II led to better integration with the surrounding new bone during an 8-week period of healing.
据报道,先前的BioGran(3i种植体创新公司,佛罗里达州棕榈滩花园)可在体外转化为羟基磷灰石(BioGran II)以加速新骨形成。本研究的目的是使用BioGran II的颗粒状和球形形式,评估植入兔胫骨临界尺寸骨缺损处的种植体周围的骨再生情况,包括种植体接触、骨与移植物接触、骨移植面积和总骨体积。
使用12只成年新西兰兔,提供24个手术部位(每只胫骨1个),在这些部位制造6毫米圆形骨缺损,以便同心插入具有Osseotite(3i种植体创新公司)表面的螺钉型实验种植体。一半的骨缺损(A组)用球形BioGran II填充,另一半(B组)用颗粒状BioGran II填充。Ossix(3i种植体创新公司)膜覆盖手术部位。
8周后的组织学评估显示两组均有新骨形成,在骨与种植体接触、骨与移植物接触、骨移植面积和骨体积方面无统计学显著差异。主要在球形颗粒中观察到颗粒外壳和内部硅胶的溶解。此外,仅在BioGran II的球形颗粒中观察到受保护袋内的新骨形成与周围新骨相互连接。
BioGran II球形颗粒的外层和内层更快溶解,导致在8周的愈合期内与周围新骨更好地整合。